“Generally I feel pretty good but I had a heart attack about 2 years ago. I get annual follow ups with bloodwork and radiologic tests. My last nuclear stress test showed I had an ejection fraction of 31%. (Normal is 50-70%. Ejection fraction is the percentage of blood pushed out the heart with each pump.) Shortly after that, I had a treatment of 90 million stem cells. I had it done to optimize my health and wellness. It was a quick and simple IV injection. I already had an echocardiogram scheduled for about 2 weeks after that. The echo results showed I had an ejection fraction of 50-54%. My ejection fraction improved over 60% in two weeks and I have done nothing new outside of the stem cell treatment. My cardiologist can’t believe it. I’m thrilled, I feel fantastic and I just want to spread the word about these stem cells.”
– Enrico D.
Not All Human Allograft Products Are Created Equal
At Prolean Wellness, we strive to offer the best to our patients in quality of service and quality of product. To that end, we choose to exclusively offer allograft tissue sourced through BioGenix and Regenerative Labs. These are umbilical cord-derived mesenchymal allografts. They are harvested from the umbilical cords and Wharton’s Jelly of full term births by Cesarean section and are then subject to the most rigorous screening standards in compliance with the FDA Current Good Manufacturing Practice (CGMP) and FDA Good Tissue Practice (GTP.)
The mother is subjected to the following screenings:
- All infections: (bacterial, viral, protozoal, etc)
- Mental health (current and past)
- Genetic and congenital abnormalities
- Drug or alcohol abuse
If the mother passes all of these screenings, then the harvested tissue is screened for:
- Outside contaminants (pesticides, herbicides, heavy metals, drugs, alcohol, medications)
Once the tissue passes those screenings, it is into the production phase during which it is run through all of those tests again, as well as for cell count and viability confirmation.
Currently, BioGenix has contracted with 44 hospitals. All of the hospitals are in California because California has the most stringent laws and guidelines regarding harvesting and processing.
Due to its reliable, consistent product quality, BioGenix is the only producer of human allograft tissue contracted with the U.S. Department of Defense and the Veteran’s Administration. BioGenix has built an impressive track record in their successful use of these particular allografts for head injuries and other traumatic injuries to our active duty soldiers.
Regenerative Labs is a one of the preeminent sources in the US for professional athletes seeking regenerative treatments. Regenative Labs’s mission is to facilitate predictable patient outcomes by offering the highest quality human tissue allografts available.
Their commitment to quality and transparency is demonstrated by collecting data from patient outcomes and analyzing it for statistical significance, ensuring physicians make the most informed decision to facilitate the best possible outcomes for patients.
There are many providers offering “stem cell” treatments. Be clear on this… the use of stem cells to help improve various conditions is a relatively new field in the U.S. A provider may actually be using PRP (platelet-rich plasma) or may harvest tissue from a person’s own body. This is not the same as what has been described above. Everyone has stem cells in their blood. As we age, that percentage of stem cells greatly diminishes. Also, as we age, so do our stem cells. The allograft tissue we use from BioGenix and Regenerative Labs are a maximum of three days old by the time they complete all of the screenings and are then frozen.